Duration and cost-effectiveness of hepatocellular carcinoma surveillance in hepatitis C patients after viral eradication

Overview of attention for article published in Journal of Hepatology, February 2022

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (96th percentile)
High Attention Score compared to outputs of the same age and source (81st percentile)

Mentioned by

twitter: 81 X users

guideline: 1 clinical guideline source

Readers on

mendeley: 50 Mendeley

So far, Altmetric has seen 100 X posts from 81 X users, with an upper bound of 222,989 followers.

RT @gnioannou: Re-evaluating *HEPATOCELLULAR CARCINOMA SURVEILLANCE* after hepatitis C eradication (SVR), for a presentation. Unsure about…

Re-evaluating *HEPATOCELLULAR CARCINOMA SURVEILLANCE* after hepatitis C eradication (SVR), for a presentation. Unsure about cost-effectiveness analysis, which suggests stopping HCC screening at age 70 in cirrhosis https://t.co/kVcydoTz8V In cirrhosis…

RT @JHepatology: Biannual surveillance for #HCC in patients cured of #HepatitisC Optimal age to stop surveillance❓ ✅#cirrhosis ➡️cost-effe…

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 96 additional X posts.